Company Filing History:
Years Active: 2003
Title: Naiming Zhou: Innovator in Synthetic Peptide Research
Introduction
Naiming Zhou is a prominent inventor based in Bala Cynwyd, PA (US). He has made significant contributions to the field of synthetic peptides, particularly in relation to HIV treatment. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Naiming Zhou holds a patent for "Chemokine-derived synthetic peptides." This patent focuses on synthetic peptide analogs of chemokines, specifically designed to include the N- and C-terminal portions of naturally occurring chemokines. The synthetic peptide analogs of stromal cell-derived factor-1 (SDF-1) are particularly noteworthy, as they have shown effectiveness in inhibiting HIV-1 entry and infection via the CXC chemokine receptor 4 (CXCR4). Each peptide comprises a segment analog of the SDF-1 N-terminal region joined to a segment analog of the SDF-1 C-terminal region. These peptides are valuable for HIV treatment and prophylaxis.
Career Highlights
Naiming Zhou is affiliated with Thomas Jefferson University, where he conducts his research and development work. His career is marked by a commitment to advancing medical science through innovative solutions.
Collaborations
Naiming Zhou collaborates with esteemed colleagues, including Ziwei Huang and Zhaowen Luo, to further enhance the impact of his research in the field of synthetic peptides.
Conclusion
Naiming Zhou's contributions to synthetic peptide research represent a significant advancement in the fight against HIV. His innovative approach and dedication to medical science continue to inspire progress in this critical area of health.